Psychopharmacology and Psychiatry Updates
En podcast av Psychopharmacology Institute
265 Avsnitt
-
Clozapine-Induced Myocarditis
Publicerades: 2022-03-08 -
Does Cannabis Use Cause Psychiatric Disorders?
Publicerades: 2022-03-03 -
Treatment Strategies for Treatment-Resistant OCD
Publicerades: 2022-02-26 -
Lithium Augmentation for Psychotic Depression
Publicerades: 2022-02-21 -
Prevention and Treatment Strategies for Agitation and Dementia
Publicerades: 2022-02-16 -
Choosing an Antipsychotic for Psychotic Depression
Publicerades: 2022-02-11 -
Neurological and Psychiatric Sequelae Due to COVID-19
Publicerades: 2022-02-06 -
SNRIs + Antipsychotics for Psychotic Depression
Publicerades: 2022-02-01 -
Approaches for Addressing Tobacco Use Disorder
Publicerades: 2022-01-27 -
ECT the First-Choice Treatment for Psychotic Depression
Publicerades: 2022-01-22 -
Metabolic Characteristics of Newer Second-Generation Antipsychotics
Publicerades: 2022-01-17 -
Prescribing Antipsychotics During Breastfeeding
Publicerades: 2022-01-12 -
Fluvoxamine for Treating COVID-19
Publicerades: 2022-01-07 -
Prescribing Antidepressants During Breastfeeding
Publicerades: 2022-01-02 -
Treatment Strategies for Acute and Chronic Insomnia
Publicerades: 2021-12-28 -
Drug Use in Breastfeeding and Adverse Effects
Publicerades: 2021-12-23 -
Marine Omega-3 Fatty Acid Supplementation for BPD
Publicerades: 2021-12-18 -
Breastfeeding and Estimating Infant Drug Exposure
Publicerades: 2021-12-13 -
A Method for Tapering Antipsychotics
Publicerades: 2021-12-08 -
Management of Psychiatric Comorbidities With Alcohol Use Disorder
Publicerades: 2021-12-03
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.